Home › Major Depressive Disorder › California › Glendale
Major Depressive Disorder clinical trials in Glendale, CA
12 studies for Major Depressive Disorder are looking for participants at sites in and around Glendale (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
RecruitingPhase 3
- Behavioral Research Specialists LLC, Glendale
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
RecruitingPhase 3
- Behavioral Research Specialists, LLC, Glendale
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
RecruitingPhase 2
- Seaport Investigator Site, Glendale
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
RecruitingPhase 2
- Behavioral Research Specialists, LLC, Glendale
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
RecruitingPhase 3
- Behavioral Research Specialists LLC, Glendale
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
RecruitingPhase 3
- Neurocrine Clinical Site, Glendale
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
RecruitingPhase 3
- Behavioral Research Specialists, Llc, Glendale
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
RecruitingPhase 3
- Neurocrine Clinical Site, Glendale
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
RecruitingPhase 3
- Clinical Research Site, Glendale
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
RecruitingPhase 2
- Behavioral Research Specialists, LLC, Glendale
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
RecruitingPhase 2
- Autobahn Site #124, Glendale
Study of ALTO-300 in MDD
RecruitingPhase 2
- Site 217, Glendale
Major Depressive Disorder trials in other cities
- New York City, NY37 studies
- Boston, MA30 studies
- Atlanta, GA24 studies
- Philadelphia, PA22 studies
- Orlando, FL19 studies
- Tampa, FL17 studies
- Miami, FL17 studies
- Chicago, IL16 studies
- Houston, TX16 studies
- San Diego, CA16 studies
- Little Rock, AR14 studies
- Austin, TX13 studies
Other studies in Glendale
- Non-Small Cell Lung Cancer9 studies
- Depression6 studies
- Cancer (all types)5 studies
- Obesity5 studies
- Lung Cancer4 studies
- Breast Cancer4 studies
- Colorectal Cancer4 studies
- Metastatic Cancer3 studies
- Macular Edema3 studies
- Melanoma3 studies
- Coronary Artery Disease3 studies
- Overweight3 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.